| Literature DB >> 36235701 |
Marko Novaković1,2, Uroš Rajkovič3, Daniel Košuta1,2, Jure Tršan1, Zlatko Fras1,2, Borut Jug1,2.
Abstract
Adherence to the Mediterranean lifestyle-as captured by the Medlife Index Questionnaire (i.e., encompassing a Mediterranean diet as well as other aspects of healthy living, such as food preparation, physical activity, and socializing)-has been associated with reduced cardiovascular events in healthy individuals. In the present study, we sought to determine the adherence to, and the effect of comprehensive cardiac rehabilitation on, Mediterranean lifestyle adherence in patients after myocardial infarction. We included 121 patients (mean age, 55 years; women, 37%) undergoing comprehensive cardiac rehabilitation-i.e., exercise training 3 times per week for 12 weeks plus dedicated workshops promoting the Mediterranean lifestyle. Before and after cardiac rehabilitation, patients completed the Medlife Index Questionnaire. High baseline adherence was associated with favourable glucose (5.39 vs. 6.1 mmol/L; p < 0.001), triglycerides (1.1 vs. 1.5 mmol/L; p = 0.002), and HDL cholesterol levels (1.32 vs. 1.12 mmol/L; p = 0.032). More importantly, the Medlife Score significantly improved following comprehensive cardiac rehabilitation in patients with low baseline adherence (from 13.8 to 16.7 points; p < 0.001), but not in patients with high baseline adherence (from 19.4 to 18.8 points; p = 0.205). Our findings suggested that Mediterranean lifestyle promotion during cardiac rehabilitation improved adherence to the Mediterranean lifestyle, especially in low-adherence patients.Entities:
Keywords: Mediterranean diet; Mediterranean lifestyle; cardiac rehabilitation; coronary artery disease; lipid status; myocardial infarction; physical activity
Mesh:
Substances:
Year: 2022 PMID: 36235701 PMCID: PMC9572874 DOI: 10.3390/nu14194048
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 6.706
Baseline demographics and clinical data.
| All (n = 121) | Low Adherence | High Adherence | Significance | |
|---|---|---|---|---|
|
| ||||
| Age, mean (SD), years | 56.0 (9.7) | 56.4 (9.1) | 54.9 (11.0) | 0.501 |
| Female sex, n (%) | 33 (27.3%) | 23 (26.4%) | 10 (29.4) | 0.741 |
| Height, mean (SD), cm | 173.0 (8.8) | 172.7 (8.3) | 173.6 (10.0) | 0.655 |
| Weight, mean (SD), kg | 85.9 (17.0) | 86.6 (17.5) | 84.2 (15.7) | 0.464 |
| BMI, mean (SD), kg/m2 | 28.6 (4.5) | 28.9 (4.7) | 27.8 (4.0) | 0.221 |
| Normal weight, n (%) | 24 (19.8%) | 16 (18.4%) | 8 (23.5%) | 0.524 |
| Overweight, n (%) | 58 (47.9%) | 40 (46.0%) | 18 (53.0%) | 0.491 |
| Obese, n (%) | 39 (32.2%) | 31 (35.6%) | 8 (23.5%) | 0.200 |
|
| ||||
| Arterial hypertension, n (%) | 55 (45.5%) | 38 (43.7%) | 17 (50.0%) | 0.530 |
| Dyslipidaemia, n (%) | 70 (57.9%) | 54 (62.1%) | 16 (47.1%) | 0.133 |
| Family history of CVD, n (%) | 49 (40.5%) | 30 (34.5%) | 19 (55.9%) | 0.031 |
| Diabetes mellitus, n (%) | 13 (10.7%) | 10 (11.5%) | 3 (8.8%) | 0.670 |
| Current cigarette smoker, n (%) | 16 (13.2%) | 13 (15.0%) | 3 (8.8%) | 0.216 |
| Former cigarette smoker, n (%) | 42 (34.7%) | 33 (37.9%) | 9 (26.5%) | |
| Never smoked, n (%) | 63 (52.1%) | 41 (47.1%) | 22 (64.7%) | |
|
| ||||
| STEMI, n (%) | 75 (62.0%) | 54 (62.1%) | 21 (61.7%) | 0.975 |
| Ejection fraction, median (Q1–Q3), % | 55 (53–56) | 55 (54–56) | 55 (50–59) | 0.998 |
| PCI LAD, n (%) | 65 (53.7%) | 49 (56.3%) | 16 (47.1%) | 0.358 |
|
| ||||
| ACEi/ARB, n (%) | 100 (82.6%) | 72 (82.8%) | 28 (82.3%) | 0.958 |
| Beta blockers, n (%) | 105 (86.8%) | 76 (87.4%) | 29 (85.3%) | 0.763 |
| Statins, n (%) | 121 (100%) | 87 (100%) | 34 (100%) | 1.000 |
| Antidiabetic therapy, n (%) | 10 (8.3%) | 8 (9.2%) | 2 (5.9%) | 0.552 |
|
| ||||
| HbA1c, mean (SD), % | 5.81 (0.75) | 5.89 (0.82) | 5.60 (0.48) | 0.027 |
|
| ||||
| Lower, n (%) | 82 (67.8%) | 64 (73.6%) | 18 (52.9%) | 0.029 |
| Higher, n (%) | 39 (32.2%) | 23 (26.4%) | 16 (47.1%) | |
|
| ||||
| Urban and suburban, n (%) | 89 (45.4%) | 62 (40.2%) | 27 (58.8%) | 0.361 |
| Rural, n (%) | 32 (26.4%) | 25 (28.7%) | 7 (20.6%) |
SD—standard deviation; BMI—body mass index; CVD—cardiovascular disease; STEMI—ST-elevation myocardial infarction; Q1–Q3—interquartile range; PCI LAD—percutaneous coronary intervention of left anterior descending artery; ACEi/ARB—angiotensin-converting enzyme inhibitor/angiotensin receptor blocker; HbA1c—glycated haemoglobin.
Effects of cardiac rehabilitation and diet counselling on blood glucose and lipid status in both examined groups.
| Low Medlife Adherence | High Medlife Adherence | Comparison between Groups ( | ||||||
|---|---|---|---|---|---|---|---|---|
| Baseline | Follow-Up |
| Baseline | Follow-Up |
| Baseline | Follow-Up | |
| Glucose | 6.08 (1.47) | 6.12 (1.43) | 0.569 | 5.39 (0.63) | 5.41 (0.71) | 0.903 | 0.001 | <0.001 |
| TChol | 3.44 (0.87) | 3.45 (0.91) | 0.928 | 3.32 (0.83) | 3.10 (0.67) | 0.236 | 0.505 | 0.034 |
| HDL | 1.12 (0.33) | 1.14 (0.36) | 0.630 | 1.26 (0.35) | 1.32 (0.34) | 0.045 | 0.032 | 0.007 |
| LDL | 1.61 (0.70) | 1.57 (0.66) | 0.431 | 1.54 (0.74) | 1.34 (0.60) | 0.272 | 0.398 | 0.068 |
| Triglycerides | 1.54 (0.71) | 1.70 (1.28) | 0.313 | 1.17 (0.63) | 1.05 (0.37) | 0.338 | 0.002 | <0.001 |
All measurements are described as mean (SD) and expressed in mmol/L. TChol—total cholesterol; HDL-c—high-density lipoprotein cholesterol; LDL-c—low-density lipoprotein cholesterol.
Figure 1Changes in the Mediterranean food consumption subdomains after the cardiac rehabilitation programme.
Figure 2Changes in the Mediterranean dietary subdomains after the cardiac rehabilitation programme.
Figure 3Changes in the social habits subdomains after the cardiac rehabilitation programme.
Changes in the specific domains of the Medlife questionnaire after the cardiac rehabilitation pro-gramme and comparison between groups.
| High Adherence to Mediterranean Lifestyle | Low Adherence to Mediterranean Lifestyle | Comparison between Groups | ||||||
|---|---|---|---|---|---|---|---|---|
| Baseline | Follow-Up |
| Baseline | Follow-Up |
| Baseline | Follow-up | |
| Medlife index | 19.4 (1.8) | 18.8 (3.0) | 0.205 | 13.8 (2.2) | 16.7 (2.7) | <0.001 | <0.001 | 0.001 |
| Mediterranean food consumption | ||||||||
| Sweets (≤2 servings/week) | 94% | 94% | 1.000 | 67% | 93% | <0.001 | 0.004 | 1.000 |
| Red meat (<2 servings/week) | 88% | 79% | 0.257 | 67% | 74% | 0.083 | 0.030 | 0.663 |
| Processed meat (≤1 serving/week) | 88% | 82% | 0.414 | 60% | 74% | 0.014 | 0.005 | 0.435 |
| Eggs (2–4 servings/week) | 68% | 44% | 0.033 | 32% | 43% | 0.061 | 0.001 | 1.000 |
| Legumes (≥2 servings/week) | 59% | 79% | 0.008 | 38% | 60% | <0.001 | 0.060 | 0.068 |
| White meat (2 servings/week) | 71% | 50% | 0.090 | 54% | 55% | 0.847 | 0.145 | 0.756 |
| Fish/seafood (≥2 servings/week) | 44% | 38% | 0.414 | 32% | 47% | 0.007 | 0.307 | 0.496 |
| Potatoes (≤3 servings/week) | 100% | 97% | 0.317 | 74% | 87% | 0.003 | 0.002 | 0.175 |
| Low-fat dairy products (2 servings/day) | 62% | 41% | 0.071 | 31% | 30% | 0.841 | 0.004 | 0.331 |
| Nuts and olives (1–2 servings/day) | 77% | 53% | 0.021 | 25% | 33% | 0.194 | <0.001 | 0.075 |
| Herbs, spices, and garnish (≥1 servings/day) | 85% | 74% | 0.102 | 63% | 71% | 0.144 | 0.032 | 0.981 |
| Fruit (3–6 servings/day) | 53% | 38% | 0.197 | 26% | 36% | 0.170 | 0.011 | 0.954 |
| Vegetables (≥2 servings/day) | 71% | 53% | 0.058 | 38% | 61% | <0.001 | 0.002 | 0.551 |
| Olive oil (≥3 servings/day) | 29% | 29% | 1.000 | 6% | 32% | <0.001 | 0.001 | 0.938 |
| Cereals (3–6 servings/day) | 38% | 24% | 0.132 | 22% | 26% | 0.414 | 0.108 | 0.922 |
| Mediterranean dietary habits | ||||||||
| Water or infusions | 65% | 50% | 0.197 | 53% | 56% | 0.480 | 0.329 | 0.589 |
| Wine | 18% | 6% | 0.102 | 9% | 5% | 0.206 | 0.214 | 0.673 |
| Limit salt in meals | 91% | 94% | 0.317 | 79% | 95% | <0.001 | 0.200 | 0.673 |
| Preference for whole-grain products | 79% | 91% | 0.046 | 63% | 72% | 0.059 | 0.134 | 0.047 |
| Snacks | 100% | 100% | 1.000 | 91% | 97% | 0.096 | 0.104 | 0.558 |
| Limit nibbling between meals | 91% | 94% | 0.564 | 74% | 92% | <0.001 | 0.061 | 1.000 |
| Limit sugar in beverages | 100% | 100% | 1.000 | 87% | 96% | 0.005 | 0.033 | 0.558 |
| Social habits | ||||||||
| Physical activity 150 min/week | 97% | 97% | 1.000 | 81% | 92% | 0.012 | 0.043 | 0.439 |
| Siesta/nap | 44% | 50% | 0.480 | 48% | 44% | 0.394 | 0.834 | 0.671 |
| Hours of sleep | 88% | 88% | 1.000 | 83% | 89% | 0.166 | 0.641 | 1.000 |
| Watching television | 35% | 35% | 1.000 | 21% | 25% | 0.248 | 0.150 | 0.381 |
| Socializing with friends | 74% | 65% | 0.317 | 53% | 63% | 0.050 | 0.062 | 1.000 |
| Collective sports | 38% | 32% | 0.480 | 16% | 23% | 0.134 | 0.017 | 0.437 |
ANCOVA tests using high vs. low adherence as a fixed factor, baseline overall Medlife Index score as a covariate, and (a) follow-up overall Medlife Index score and (b) overall Medlife Index score difference, as dependent variables.
| (a) Dependent Variable: Follow-Up Overall Medlife Index Score | ||||||
|---|---|---|---|---|---|---|
|
| Type III Sum of Squares |
| Mean Square | F | Sig. | Partial Eta Squared |
| Corrected model | 347.806 * | 2 | 173.903 | 30.255 | 0.000 | 0.339 |
| Intercept | 69.921 | 1 | 69.921 | 12.164 | 0.001 | 0.093 |
| Baseline overall Medlife Index Score | 240.060 | 1 | 240.060 | 41.764 | 0.000 | 0.261 |
| High adherence vs. Low adherence | 31.369 | 1 | 31.369 | 5.457 | 0.021 | 0.044 |
| Error | 678.260 | 118 | 5.748 | |||
| Total | 37,299.000 | 121 | ||||
| Corrected total | 1026.066 | 120 | ||||
|
| ||||||
|
|
|
|
|
|
|
|
| Corrected model | 355.211 ** | 2 | 177.605 | 30.899 | 0.000 | 0.344 |
| Intercept | 69.921 | 1 | 69.921 | 12.164 | 0.001 | 0.093 |
| Baseline overall Medlife Index Score | 47.355 | 1 | 47.355 | 8.239 | 0.005 | 0.065 |
| High adherence vs. Low adherence | 31.369 | 1 | 31.369 | 5.457 | 0.021 | 0.044 |
| Error | 678.260 | 118 | 5.748 | |||
| Total | 1486.000 | 121 | ||||
| Corrected total | 1033.471 | 120 | ||||
Legend: * R squared = 0.339 (adjusted R squared = 0.328), ** R squared = 0.344 (adjusted R squared = 0.333).